Ad is loading...
ARDX
Price
$5.59
Change
-$0.08 (-1.41%)
Updated
Dec 2, 03:38 PM (EDT)
93 days until earnings call
HRTX
Price
$1.21
Change
+$0.02 (+1.68%)
Updated
Dec 2, 04:00 PM (EDT)
80 days until earnings call
Ad is loading...

ARDX vs HRTX

Header iconARDX vs HRTX Comparison
Open Charts ARDX vs HRTXBanner chart's image
Ardelyx
Price$5.59
Change-$0.08 (-1.41%)
Volume$11.51K
CapitalizationN/A
Heron Therapeutics
Price$1.21
Change+$0.02 (+1.68%)
Volume$140.18K
CapitalizationN/A
ARDX vs HRTX Comparison Chart
Loading...
ARDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
HRTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ARDX vs. HRTX commentary
Dec 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARDX is a Hold and HRTX is a Hold.

COMPARISON
Comparison
Dec 02, 2024
Stock price -- (ARDX: $5.67 vs. HRTX: $1.19)
Brand notoriety: ARDX and HRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARDX: 60% vs. HRTX: 45%
Market capitalization -- ARDX: $1.34B vs. HRTX: $180.99M
ARDX [@Biotechnology] is valued at $1.34B. HRTX’s [@Biotechnology] market capitalization is $180.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $476.43B to $0. The average market capitalization across the [@Biotechnology] industry is $2.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARDX’s FA Score shows that 0 FA rating(s) are green whileHRTX’s FA Score has 0 green FA rating(s).

  • ARDX’s FA Score: 0 green, 5 red.
  • HRTX’s FA Score: 0 green, 5 red.
According to our system of comparison, ARDX is a better buy in the long-term than HRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARDX’s TA Score shows that 4 TA indicator(s) are bullish while HRTX’s TA Score has 4 bullish TA indicator(s).

  • ARDX’s TA Score: 4 bullish, 5 bearish.
  • HRTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, HRTX is a better buy in the short-term than ARDX.

Price Growth

ARDX (@Biotechnology) experienced а +6.78% price change this week, while HRTX (@Biotechnology) price change was +11.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.63%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was +11.60%.

Reported Earning Dates

ARDX is expected to report earnings on Mar 05, 2025.

HRTX is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (+4.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARDX($1.34B) has a higher market cap than HRTX($181M). ARDX YTD gains are higher at: -8.548 vs. HRTX (-30.000). HRTX has higher annual earnings (EBITDA): -19.37M vs. ARDX (-53.06M). ARDX has more cash in the bank: 190M vs. HRTX (70.9M). ARDX has less debt than HRTX: ARDX (104M) vs HRTX (178M). ARDX has higher revenues than HRTX: ARDX (252M) vs HRTX (138M).
ARDXHRTXARDX / HRTX
Capitalization1.34B181M742%
EBITDA-53.06M-19.37M274%
Gain YTD-8.548-30.00028%
P/E RatioN/AN/A-
Revenue252M138M183%
Total Cash190M70.9M268%
Total Debt104M178M58%
FUNDAMENTALS RATINGS
ARDX vs HRTX: Fundamental Ratings
ARDX
HRTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
91100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
5993
P/E GROWTH RATING
1..100
59100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HRTX's Valuation (69) in the Biotechnology industry is in the same range as ARDX (98). This means that HRTX’s stock grew similarly to ARDX’s over the last 12 months.

ARDX's Profit vs Risk Rating (91) in the Biotechnology industry is in the same range as HRTX (100). This means that ARDX’s stock grew similarly to HRTX’s over the last 12 months.

ARDX's SMR Rating (97) in the Biotechnology industry is in the same range as HRTX (100). This means that ARDX’s stock grew similarly to HRTX’s over the last 12 months.

ARDX's Price Growth Rating (59) in the Biotechnology industry is somewhat better than the same rating for HRTX (93). This means that ARDX’s stock grew somewhat faster than HRTX’s over the last 12 months.

ARDX's P/E Growth Rating (59) in the Biotechnology industry is somewhat better than the same rating for HRTX (100). This means that ARDX’s stock grew somewhat faster than HRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARDXHRTX
RSI
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
86%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 14 days ago
81%
Bearish Trend 12 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
88%
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
N/A
View a ticker or compare two or three
Ad is loading...
ARDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
HRTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DBMZX30.290.11
+0.36%
BNY Mellon Sm/Md Cp Gr Z
PGSVX12.260.03
+0.25%
Pioneer Global Sustainable Value A
WFTDX14.160.02
+0.14%
Allspring Innovation Fund - Class Admin
DEVCX60.280.01
+0.02%
Delaware Small Cap Value C
ABCEX8.69N/A
N/A
AB Emerging Markets Multi-Asset C

ARDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARDX has been loosely correlated with VCYT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ARDX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARDX
1D Price
Change %
ARDX100%
-0.35%
VCYT - ARDX
45%
Loosely correlated
+0.14%
HRTX - ARDX
41%
Loosely correlated
+2.59%
PTGX - ARDX
40%
Loosely correlated
-2.56%
NKTX - ARDX
39%
Loosely correlated
-4.01%
BCRX - ARDX
39%
Loosely correlated
N/A
More